Let’s explore the implications of this clinical achievement for Kodiak’s market position, the calculations behind its current ...
The post-pandemic bubble popped, but life sciences aren’t going anywhere. Blackstone announced Monday that it closed ...
Abbott closes $21B acquisition of Exact Sciences (EXAS) at $105/share. EXAS delisted from Nasdaq on March 23, 2026, becoming ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences VI ("BXLS VI"). BXLS VI was oversubscribed ...
Kodiak Sciences Inc. KOD shares are up on Thursday following the announcement of positive topline results in the GLOW2 Phase ...
The labs are not all right. After years of new supply without the tenant demand to support it, life sciences real estate nationwide is at an inflection point, with 18.7M SF likely to change uses by ...
Wave Life Sciences has plummeted after two Wall Street firms cut price targets following updated trial data for the company's ...
The subject area represents the next stage of the database’s evolution, and heralds other proposed changes to journal selection and article categorization. The first Nature Index tables in the applied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results